Canada markets open in 1 hour 12 minutes

RLMD Jan 2025 5.000 put

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
2.40000.0000 (0.00%)
As of 04:40PM EDT. Market open.
Full screen
Loading interactive chart...
  • PR Newswire

    Relmada Therapeutics Announced Publication of Results from the Phase 3 Reliance I Study of REL-1017 in The Journal of Clinical Psychiatry

    Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today announced the publication of REL-1017 clinical data from the Reliance I Study in the peer-reviewed journal, The Journal of Clinical Psychiatry. The article is titled, "Efficacy and Safety of Esmethadone (REL-1017) in Patients with Major Depressive Disorder and Inadequate Response to Standard Antidepressants: A Phase 3 Randomized Controlled Trial", and is av

  • PR Newswire

    Relmada Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

    Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today announced that Sergio Traversa, Chief Executive Officer, will participate in a fireside chat at the 2024 Goldman Sachs Global Healthcare Conference in Miami, Florida on Wednesday, June 12, 2024, at 11:20am ET. Management will also host one-on-one investor meetings. Please find additional details about the event below.

  • PR Newswire

    Relmada Therapeutics to Participate in the 2024 Jefferies Global Healthcare Conference

    Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today announced that Sergio Traversa, Chief Executive Officer, and Maged Shenouda, Chief Financial Officer, will participate in a fireside chat on Thursday, June 6, 2024, at 7:30am ET at the 2024 Jefferies Global Healthcare Conference in New York, NY. Management will also host one-on-one investor meetings. Please find additional details about the event below.